Related Experiment Videos
Current management of atrial fibrillation
1Boston University School of Medicine, Massachusetts.
Current Opinion in Cardiology
|January 1, 1994
Summary
Research explores atrial fibrillation (AF) management, including anticoagulation risks and benefits, ventricular rate control, and post-cardioversion recovery. New diagnostic and therapeutic strategies are emerging for this common arrhythmia.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Background:
- Atrial fibrillation (AF) is experiencing renewed research interest.
- Understanding AF's electrical behavior and optimizing patient management are key challenges.
Purpose of the Study:
- To review current research avenues in atrial fibrillation.
- To highlight ongoing investigations into anticoagulation, rate control, cardioversion outcomes, and novel therapies.
Main Methods:
- Review of recent observational studies and clinical trials.
- Analysis of risk factors for stroke in AF patients.
- Evaluation of diagnostic tools like transesophageal echocardiography.
- Assessment of new therapeutic and surgical approaches.
Main Results:
- Anticoagulation's risk-benefit ratio in average patients remains unclear, prompting comparative trials.
- Digoxin's slow action and potential for suboptimal dosing in rate control are noted.
- Post-cardioversion exercise capacity improvements may be delayed; sinus rhythm can improve ejection fraction.
- Transesophageal echocardiography is crucial for identifying thromboembolism risk.
Conclusions:
- Ongoing research aims to clarify anticoagulation efficacy and safety.
- New diagnostic and therapeutic strategies, including surgical interventions, are expanding treatment options for atrial fibrillation.